Capricor Therapeutics (CAPR) Receivables - Other (2012 - 2025)
Capricor Therapeutics (CAPR) posted quarterly Receivables - Other of $10.0 million for Q4 2024, little changed year-over-year from $10.0 million in Q1 2024, and little changed quarter-over-quarter from $10.0 million in Q4 2023.
Powered by 
Analysis
Capricor Therapeutics (CAPR) Receivables - Other (2012 - 2025) Analysis & Trends
Capricor Therapeutics' Receivables - Other history runs 10 years deep, the most recent figure standing at $10.0 million for Q4 2024.
- In Q4 2024, Receivables - Other changed 0.0% year-over-year to $10.0 million; the TTM figure through Dec 2024 stood at $10.0 million (changed 0.0% YoY), while the FY2024 annual figure was $10.0 million, changed 0.0% from the prior year.
- Receivables - Other for Q4 2024 stood at $10.0 million, roughly flat from $10.0 million in the prior quarter.
- The five-year high for Receivables - Other was $10.0 million in Q4 2023, with the low at $385.0 in Q2 2020.
- The 4-year median for Receivables - Other is $206000.0 (2021), against an average of $3.0 million.
- The sharpest annual moves came in 2020 and 2021: Receivables - Other dropped 3.45% in 2020, then soared 53406.49% in 2021.
- Capricor Therapeutics' Receivables - Other stood at $56000.0 in 2020, then surged by 267.86% to $206000.0 in 2021, then jumped by 4754.37% to $10.0 million in 2023, then changed by 0.0% to $10.0 million in 2024.
- Business Quant data shows CAPR's Receivables - Other at $10.0 million in Q4 2024, $10.0 million in Q4 2023, and $206000.0 in Q2 2021.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Capricor Therapeutics | 543.30 Mn | 543.30 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 59,167.00 |
| Sep 30, 2025 | 59,167.00 |
| Jun 30, 2025 | 59,509.00 |
| Mar 31, 2025 | 59,834.00 |
| Dec 31, 2024 | 10.37 Mn |
| Sep 30, 2024 | 409,682.00 |
| Jun 30, 2024 | 369,975.00 |
| Mar 31, 2024 | 369,000.00 |
| Dec 31, 2023 | 10.37 Mn |
| Sep 30, 2023 | 547,580.00 |
| Jun 30, 2023 | 547,580.00 |
| Mar 31, 2023 | 547,580.00 |
| Dec 31, 2022 | 547,580.00 |
| Sep 30, 2022 | 547,580.00 |
| Jun 30, 2022 | 547,580.00 |
| Mar 31, 2022 | 356,997.00 |
| Dec 31, 2021 | 391,750.00 |
| Sep 30, 2021 | 180,178.00 |
| Jun 30, 2021 | 206,000.00 |
| Mar 31, 2021 | 600,000.00 |